ABSTRACT SUBMISSION
We are pleased to invite you to submit your abstracts for EPOS 2027.
Important Dates
- • Abstract Submission Opens: 1 September 2026
- • Abstract Submission Deadline: 30 September 2026
- • Evaluation Deadline: 18 November 2026
Abstract Submission Guidelines
Please carefully read the following guidelines before submitting your abstract:
- The abstract must not exceed 300 words. The title is not included in the word count.
- The title should be as brief as possible while clearly indicating the nature of the study. The title is limited to a maximum of 200 characters, including spaces.
- As a blind review process will be used, no identifying information such as author names, hospitals, medical schools, clinics, institutions, or cities may be included in the title or abstract text. Author names and institutional affiliations will be entered separately during the online submission process.
-
The abstract must include the following sections:
- Objective: Clearly state the purpose and main objective of the study.
- Methods: Briefly describe the study design, subjects, and methods used.
- Results: Present the main findings clearly and logically.
- Conclusion and Significance: Summarize the key conclusions and highlight the significance and implications of the findings.
- You may upload only
one figure or one table. Submissions containing both will not be considered. Graphics or figures must be submitted in JPG or TIFF format. - All abbreviations must be defined at their first appearance.
- Statements such as "results will be discussed" or "data will be presented" are not acceptable.
- References, acknowledgements/credits, and grant support information must not be included in the abstract.
- Use of Brand Names: Generic names must be used when referring to products or companies. A brand name may be provided as a reference at the bottom of the abstract page. Abstracts containing brand names or company names within the abstract text may be rejected on this basis alone. EPOS reserves the right to replace any brand name with its generic name without prior notice.
Abstract Topics
Abstracts may be submitted under one of the following topics:
- • Basic Science
- • Hip
- • Lower Limb Deformity
- • Foot & Ankle
- • Dysplasia, Congenital & Syndromic
- • Miscellaneous
- • Neuromuscular
- • Spine
- • Sports
- • Trauma
- • Tumours & Infections
- • Upper Limb & Hand
Abstract Review and Acceptance
- All submitted abstracts will be reviewed by the EPOS Reading Committee.
- Notification of abstract acceptance will be sent directly to the presenting author by email.
- All investigators are responsible for ensuring that their studies have been conducted in accordance with applicable national and international legislation and ethical guidelines for medical research involving humans and/or animals. The EPOS Reading Committee reserves the right to reject any abstract that is considered to violate these principles.
- Please ensure that the email addresses provided for both the submitter and presenting author are correct, as these addresses will be used for all communication following the review process.
- A maximum of 2 accepted podium presentations per presenter is permitted. There is no limit on the number of accepted ePoster presentations per presenter.
- An Olympic scoring system will be used for abstract evaluation. The highest and lowest scores will be excluded, and the arithmetic mean of the remaining scores will be calculated. Abstracts receiving the highest final scores will be selected as Podium Abstracts.
- Please note that registration for the 45th EPOS Annual Meeting 2027 is mandatory for the presenting author. Accepted abstracts will only be published if the presenting author is registered for the annual meeting.
Abstract Submission
Abstract submission opens on 1 September 2026.
Please make sure to complete your submission before the deadline:
30 September 2026
For all enquiries regarding abstract submission, please contact the local PCO: